Revvity (RVTY) Stock Forecast, Price & News

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Revvity in the last twelve months. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" RVTY shares.
View RVTY analyst ratings or view top-rated stocks.

5 analysts have issued 1 year target prices for Revvity's shares. Their RVTY share price forecasts range from $130.00 to $147.00. On average, they predict the company's stock price to reach $138.00 in the next twelve months. This suggests a possible upside of 24.5% from the stock's current price.
View analysts price targets for RVTY or view top-rated stocks among Wall Street analysts.

Revvity's stock was trading at $116.84 on January 1st, 2023. Since then, RVTY shares have decreased by 5.1% and is now trading at $110.88.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our RVTY earnings forecast.

Revvity, Inc. (NYSE:RVTY) announced its quarterly earnings results on Tuesday, August, 1st. The company reported $1.21 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.19 by $0.02. The company had revenue of $709.10 million for the quarter, compared to the consensus estimate of $708.61 million. Revvity had a trailing twelve-month return on equity of 9.06% and a net margin of 29.19%. The business's revenue for the quarter was down 20.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.32 earnings per share.

Revvity declared a quarterly dividend on Friday, July 21st. Investors of record on Friday, October 20th will be given a dividend of $0.07 per share on Friday, November 10th. This represents a $0.28 dividend on an annualized basis and a yield of 0.25%. The ex-dividend date of this dividend is Thursday, October 19th.
Read our dividend analysis for RVTY.

ETFs with the largest weight of Revvity (NYSE:RVTY) stock in their portfolio include ROBO Global Healthcare Technology and Innovation ETF (HTEC), Invesco S&P 500 Equal Weight Health Care ETF (RSPH), Invesco S&P 500 Equal Weight Health Care ETF (RYH), Franklin Genomic Advancements ETF (HELX), Global X Guru Index ETF (GURU), T. Rowe Price Capital Appreciation Equity ETF (TCAF), Pacer US Export Leaders ETF (PEXL) and First Trust Large Cap Value AlphaDEX Fund (FTA).

Revvity (NYSE:RVTY) pays an annual dividend of $0.28 per share and currently has a dividend yield of 0.26%. The dividend payout ratio is 4.28%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, RVTY will have a dividend payout ratio of 5.05% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for RVTY.

Revvity issued an update on its FY 2023 earnings guidance on Tuesday, August, 1st. The company provided EPS guidance of $4.70-$4.90 for the period, compared to the consensus estimate of $4.94. The company issued revenue guidance of $2.80 billion-$2.85 billion, compared to the consensus revenue estimate of $2.91 billion.

Revvity trades on the New York Stock Exchange (NYSE) under the ticker symbol "RVTY."

Shares of RVTY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of RVTY stock can currently be purchased for approximately $110.88.

Revvity (NYSE:RVTY) has a market capitalization of $13.76 billion and generates $3.31 billion in revenue each year. The company earns $569.18 million in net income (profit) each year or $6.54 on an earnings per share basis.

The company employs 16,700 workers across the globe.

Revvity's mailing address is 940 WINTER STREET, WALTHAM MA, 02451. The official website for the company is www.perkinelmer.com. The company can be reached via phone at (781) 663-6900, via email at ir@perkinelmer.com, or via fax at 781-663-5985.